Os Therapies Incorporated Stock Revenue
| OSTX Stock | 5.11 1.28 33.42% |
OS Therapies Incorporated fundamentals help investors to digest information that contributes to OS Therapies' financial success or failures. It also enables traders to predict the movement of OSTX Stock. The fundamental analysis module provides a way to measure OS Therapies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to OS Therapies stock.
| Last Reported | Projected for Next Year |
OSTX |
OS Therapies Incorporated Company Revenue Analysis
OS Therapies' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Historical and Projected quarterly revenue of OSTX
Projected quarterly revenue analysis of OS Therapies provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of OS Therapies match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in OS Therapies' stock price.
OSTX Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for OS Therapies is extremely important. It helps to project a fair market value of OSTX Stock properly, considering its historical fundamentals such as Revenue. Since OS Therapies' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of OS Therapies' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of OS Therapies' interrelated accounts and indicators.
Click cells to compare fundamentals
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, OS Therapies Incorporated reported 0.0 of revenue. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
OSTX Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses OS Therapies' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of OS Therapies could also be used in its relative valuation, which is a method of valuing OS Therapies by comparing valuation metrics of similar companies.OS Therapies is currently under evaluation in revenue category among its peers.
OSTX Fundamentals
| Current Valuation | 90.74 M | ||||
| Shares Outstanding | 20.88 M | ||||
| Shares Owned By Insiders | 24.83 % | ||||
| Number Of Shares Shorted | 8.93 K | ||||
| EBITDA | (3.18 M) | ||||
| Net Income | (7.79 M) | ||||
| Total Debt | 14.61 M | ||||
| Book Value Per Share | (4.52) X | ||||
| Cash Flow From Operations | (3.01 M) | ||||
| Short Ratio | 0.01 X | ||||
| Earnings Per Share | (0.32) X | ||||
| Target Price | 15.0 | ||||
| Market Capitalization | 74.14 M | ||||
| Total Asset | 798.08 K | ||||
| Retained Earnings | (29.52 M) | ||||
| Working Capital | (23.92 M) | ||||
| Net Asset | 798.08 K |
About OS Therapies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze OS Therapies Incorporated's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OS Therapies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OS Therapies Incorporated based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for OSTX Stock Analysis
When running OS Therapies' price analysis, check to measure OS Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OS Therapies is operating at the current time. Most of OS Therapies' value examination focuses on studying past and present price action to predict the probability of OS Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OS Therapies' price. Additionally, you may evaluate how the addition of OS Therapies to your portfolios can decrease your overall portfolio volatility.